Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$6.636M
Current Assets
Last 4 Quarters
N/A
Current Liabilities
Last 4 Quarters
N/A
Current Ratio
Last 4 Quarters
N/A
Total Assets
Last 4 Quarters
N/A
Total Liabilities
Last 4 Quarters
N/A
Book Value
Last 4 Quarters
N/A
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$2.388M

Stock Price

Loading...
Market Cap: $2.9654 Million

About Clearmind Medicine Inc

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.

Industry: Pharmaceutical Preparations Peers: InMed Pharmaceuticals Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support